Journal of Alzheimers Disease

Papers
(The H4-Index of Journal of Alzheimers Disease is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Needs of people living with young-onset dementia and family carers, explored by dementia subtype, phase in the disease process, and living setting: A scoping review190
Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer’s Disease157
Japan-multimodal intervention trial for the prevention of dementia in older people with lifestyle-related diseases: A community-based, 18-month, randomized controlled trial132
Individual electric field in cortical white matter is correlated with cognitive improvement in patients with mild cognitive impairment due to Alzheimer's disease after repetitive transcranial magnetic127
p53 SUMOylation promotes neurogenesis defects in APP/PS1 mice105
Peripheral blood immune cell phenotypes and Alzheimer’s disease: A mediation Mendelian randomization study101
Hydrate to keep the amyloid away88
From autopsy to PET to cerebrospinal fluid to blood: Quantifying reference-standard dependence in Alzheimer's disease amyloid biomarker validation85
Sex-specific accelerated epigenetic aging in the Alzheimer's disease spectrum83
Altered temporal dynamics of intrinsic brain activity in mild cognitive impairment with olfactory dysfunction71
IL-34/TREM2 modulates microglia-mediated inflammation and provides neuroprotection in a mouse model of sporadic Alzheimer's disease68
The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer’s Disease Continuum: A Systematic Review and Meta-Analysis66
Under-Diagnosis of Dementia with Lewy Bodies in Individuals Racialized as Black: Hypotheses Regarding Potential Contributors65
HARMONISATION – A multimodal prospective study of vascular cognitive impairment in multi-ethnic Asians: Cohort profile, progress, current contributions, and future impact62
Dementia in Denmark: Uncovering the causes of death and life years lost in a nationwide, register-based cohort study62
Neurophysiological Alterations of the Visual Pathway in Posterior Cortical Atrophy: Systematic Review and a Case Series60
Comparison of visit-to-visit blood pressure variability and time in target range in predicting risk for cognitive outcomes in the SPRINT trial60
The association between dual sensory impairment and dementia: A systematic review and meta-analysis60
One of the binding proteins for administered amyloid-β appears to be anti-Aβ IgG antibody in amyloid plaques60
Unraveling the impact of risk factors on the ferroptosis-Alzheimer's disease link for early detection59
Soda consumption and risk of dementia: The Northern Manhattan study54
Diagnostic accuracy of Alzheimer's Questionnaire in identifying dementia among Filipinos in a tertiary hospital53
Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia52
Mediation effect of neuropsychological factors on the relationship between social networks and mild cognitive impairment in older adults50
FTIR Spectroscopy and Blood-Derived Extracellular Vesicles Duo in Alzheimer’s Disease50
Novel predictors of Alzheimer's disease in Down syndrome identified using machine learning49
Corrigendum to “Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer's Disease and Down Syndrome”49
Blood pressure dynamic instability and neurodegeneration in older adults48
Regional gyrification alterations and metabolic correlates in biologically defined Alzheimer's disease using a multimodal approach46
Cerebrospinal fluid acetylcholine is not a reliable diagnostic marker for Alzheimer's disease and dementia with Lewy bodies46
Multimorbidity, Social Engagement, and Age-Related Cognitive Decline in Older Adults from the Rancho Bernardo Study of Healthy Aging46
Patterns of cortical atrophy are associated with specific cognitive domains in patients with logopenic primary progressive aphasia45
Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's disease44
Uncovering pathology, subjective cognitive complaints, and sex in early Alzheimer's disease44
Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer’s Disease Not Using Neuroimaging Biomarkers: A Systematic Review43
Relationship periodontitis and Alzheimer's disease: Relevant aspects from an epigenetic view43
Exploring the potential of acupuncture as a complementary treatment for Alzheimer's disease: Pushing the boundaries forward42
Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer’s Disease40
Putting the Brakes on Accelerated Cognitive Decline in Alzheimer’s Disease with Epileptic Activity40
Late Midlife Subclinical Infarct Burden and Risk of Dementia: The Atherosclerosis Risk in Communities Neurocognitive Study40
Vitamin D, a Secosteroid Hormone and Its Multifunctional Receptor, Vitamin D Receptor, in Alzheimer’s Type Neurodegeneration40
Assessing Longitudinal Cognitive Change in Mild Cognitive Impairment Using Estimated Standardized Regression-Based Formulas40
Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer’s Disease40
Sex-Related Differences in the Association Between Body Mass Index and Dementia Risk40
0.19631886482239